Date | Title | Description | |
---|---|---|---|
15 Mar 2022 | On significant placements in financial instruments | Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. | Download |
14 Mar 2022 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. | Download |
23 Feb 2022 | On business and financial situation | The Company releases the press release related to the full year 2021 financial results | Download |
23 Feb 2022 | On business and financial situation | The Company releases the full year 2021 financial results presentation | Download |
23 Feb 2022 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
Pages
Date | Title | Description | |
---|---|---|---|
15 Feb 2022 | On business and financial situation | ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. | Download |
14 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022 | Download |
07 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022 | Download |
31 Jan 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022 | Download |
24 Jan 2022 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
17 Mar 2016 | Acuerdos estratégicos con terceros | Enervit Nutrition, joint venture of ROVI and Enervit, will distribute nutritional products in Spain and Portugal | Download |
24 Feb 2016 | Información sobre resultados (2) | ROVI releases the press release related to the full year 2015 results | Download |
24 Feb 2016 | Información sobre resultados | ROVI releases the press release related to the full year 2015 results | Download |
24 Feb 2016 | Contratos de liquidez y contrapartida | The Company informs that it has signed a liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download |
24 Feb 2016 | Informe Anual de Gobierno Corporativo 2015 | ROVI releases the 2015 Annual Corporate Governance Report | Download |